SCHEMBL22853040

SCHEMBL22853040

CCOC(=O)c1cc(C(F)(F)F)ccc1Nc1ccc(F)cc1OC

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CDC25B P30305 3/20 0.48
ALDH1A1 P00352 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
MRGPRX4 Q96LA9 1/20 0.45
SCN8A Q9UQD0 3/20 0.45
SCN10A Q9Y5Y9 3/20 0.45
PDE5A O76074 2/20 0.44
PDE6D O43924 1/20 0.44
PDE6A P16499 1/20 0.44
PDE6G P18545 1/20 0.44
PDE6B P35913 1/20 0.44
PDE6C P51160 1/20 0.44
PDE6H Q13956 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
LRRK2 Q5S007 1/20 0.41
THRB P10828 1/20 0.41
MPO P05164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30294858 1.00 CDC25B (0.48) CDC25BALDH1A1RXFP1MRGPRX4SCN8A
SCHEMBL30294309 0.92 CDC25B (0.47) CDC25BALDH1A1RXFP1MRGPRX4SCN8A
SCHEMBL22853410 0.92 CDC25B (0.47) CDC25BALDH1A1RXFP1MRGPRX4SCN8A
SCHEMBL22853044 0.89 MAPT (0.49) CDC25BALDH1A1PDE5APDE6DPDE6A
SCHEMBL30294496 0.89 MAPT (0.49) CDC25BALDH1A1PDE5APDE6DPDE6A
SCHEMBL22853414 0.87 MRGPRX4 (0.45) MRGPRX4SCN8ASCN10ACYP1A2CYP2C9
SCHEMBL30294513 0.87 MRGPRX4 (0.45) MRGPRX4SCN8ASCN10ACYP1A2CYP2C9
SCHEMBL22853079 0.85 MPO (0.57) ALDH1A1RXFP1SCN8ASCN10ACYP2C19
SCHEMBL30294712 0.85 MPO (0.57) ALDH1A1RXFP1SCN8ASCN10ACYP2C19
SCHEMBL22853053 0.83 MRGPRX4 (0.42) CDC25BMRGPRX4CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020261114-A1 2,3-DIHYDROQUINAZOLIN COMPOUNDS AS NAV1.8 INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2020-12-30 WO disclosed